Series E - NGM Biopharmaceuticals - Mar 25, 2015 Funding Round Profile - Cointime

Bitcoin $79,689.64 +4.13%
Ethereum $3,205.13 +4.91%
BNB $635.35 +1.42%
Optimism $1.67 +1.21%
Arbitrum $0.64 +4.40%
Solana $205.31 +1.22%
Polygon $0.41 +5.14%
Cosmos $5.26 +9.98%
Avalanche $32.03 +8.50%

Bitcoin $79,689.64 +4.13%
Ethereum $3,205.13 +4.91%
BNB $635.35 +1.42%
Optimism $1.67 +1.21%
Arbitrum $0.64 +4.40%
Solana $205.31 +1.22%
Polygon $0.41 +5.14%
Cosmos $5.26 +9.98%
Avalanche $32.03 +8.50%

NGM Biopharmaceuticals

company

Funding Round

Series E

Money Raised

$ 105.99M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	Yes	-	Detail